About the Company
Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $MYL News
Mylan Investors’ Appeal Draws Scrutiny from Second Circuit Panel
Mylan N.V. investors’ attempt to revive class action claims that the pharmaceutical company hid price fixing practices and ...
Global Local Anesthesia Drugs Market Forecast Reveals High Demand and Expansion by 2029
Dublin, March 26, 2024 (GLOBE NEWSWIRE) -- The "Global Local Anesthesia Drugs - Market Share Analysis, Industry Trends & ...
Overview of the Hormone Replacement Therapy Market
Hormone Replacement Therapy (HRT) addresses hormonal imbalances, alleviating symptoms and improving quality of life. The market encompasses various hormone formulations and delivery methods tailored ...
Global Substance Abuse Treatment Market Poised For Substantial Growth, Forecasted To Surpass USD 18.0 Billion By 2032 | Marketresearch.Biz Report
Marketresearch.biz reports that the substance abuse treatment market size was projected at USD 9.5 billion in 2022 and is predicted to grow at a CAGR of 6.8% from 2023 to 2032. It is expected to reach ...
Diabetic Kidney Disease Global Market Research Report 2024
The "Diabetic Kidney Disease Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The diabetic kidney disease market size has grown strongly in recent years. It will ...
Loading the latest forecasts...